The global albendazole drug market is witnessing steady expansion, driven by increasing awareness of parasitic infections and large-scale public health initiatives. The albendazole drug market is projected to grow at a CAGR of 6.4% during 2026–2034, reflecting consistent demand across both human and veterinary healthcare sectors. The market encompasses various dosage forms such as tablets...